MDMA

Lykos Offers New Measures for Additional Oversight if MDMA-AT Is Approved
How the FDA MDMA Decision Affects Therapists and Trainers
Can Lykos Therapeutics Address MDMA-AT Safety Concerns Ahead of FDA Decision?
How MAPS PBC Became Lykos Therapeutics and Raised $100M
MAPS PBC Filing of New Drug Application to FDA Seen as Milestone
First Study to Look at Candy Flipping Suggests Potential for Psychedelic Therapy
Psychedelics May Reopen Locked Learning Opportunities
Will the Psychedelic Revolution Be Medicalized?
Ann Shulgin, Forerunner of Today’s Psychedelic Reemergence, Dies at 91 
Celebrating the Psychedelic Dawn